Pharma & Healthcare
Global OTC Pain Medicines Market Research Report 2025
- Jul 28, 25
- ID: 409393
- Pages: 99
- Figures: 97
- Views: 7
The global market for OTC Pain Medicines was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Over-the-counter pain relievers are many common products used to treat headaches, colds, and menstrual cramps. Common over-the-counter pain relievers include paracetamol and non-steroidal anti-inflammatory drugs such as aspirin and low-dose ibuprofen. Non-opioid medications - medications that treat pain. Non-opioid prescription medications include diclofenac and ibuprofen.
This report aims to provide a comprehensive presentation of the global market for OTC Pain Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Pain Medicines.
The OTC Pain Medicines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global OTC Pain Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Pain Medicines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Pfizer
Novartis
Sanofi
Bayer
Mallinckrodt
Anqiu Lu'an
Granules India
Farmson
Hebei Jiheng
Zhejiang Kangle
Sri Krishna Pharma
Anhui BBCA Likang
Seqens
Xinhua Pharmaceutical
IOLCP
Granules Biocause
Strides Shasun
Segment by Type
Acetaminophen
Ibuprofen
Aspirin
Naproxen
Others
Segment by Application
Hospital Pharmacies
Drug Stores
E-Commerce
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of OTC Pain Medicines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Over-the-counter pain relievers are many common products used to treat headaches, colds, and menstrual cramps. Common over-the-counter pain relievers include paracetamol and non-steroidal anti-inflammatory drugs such as aspirin and low-dose ibuprofen. Non-opioid medications - medications that treat pain. Non-opioid prescription medications include diclofenac and ibuprofen.
This report aims to provide a comprehensive presentation of the global market for OTC Pain Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Pain Medicines.
The OTC Pain Medicines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global OTC Pain Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Pain Medicines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Pfizer
Novartis
Sanofi
Bayer
Mallinckrodt
Anqiu Lu'an
Granules India
Farmson
Hebei Jiheng
Zhejiang Kangle
Sri Krishna Pharma
Anhui BBCA Likang
Seqens
Xinhua Pharmaceutical
IOLCP
Granules Biocause
Strides Shasun
Segment by Type
Acetaminophen
Ibuprofen
Aspirin
Naproxen
Others
Segment by Application
Hospital Pharmacies
Drug Stores
E-Commerce
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of OTC Pain Medicines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Pain Medicines Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Acetaminophen
1.2.3 Ibuprofen
1.2.4 Aspirin
1.2.5 Naproxen
1.2.6 Others
1.3 Market by Application
1.3.1 Global OTC Pain Medicines Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 E-Commerce
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Pain Medicines Market Perspective (2020-2031)
2.2 Global OTC Pain Medicines Growth Trends by Region
2.2.1 Global OTC Pain Medicines Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 OTC Pain Medicines Historic Market Size by Region (2020-2025)
2.2.3 OTC Pain Medicines Forecasted Market Size by Region (2026-2031)
2.3 OTC Pain Medicines Market Dynamics
2.3.1 OTC Pain Medicines Industry Trends
2.3.2 OTC Pain Medicines Market Drivers
2.3.3 OTC Pain Medicines Market Challenges
2.3.4 OTC Pain Medicines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Pain Medicines Players by Revenue
3.1.1 Global Top OTC Pain Medicines Players by Revenue (2020-2025)
3.1.2 Global OTC Pain Medicines Revenue Market Share by Players (2020-2025)
3.2 Global OTC Pain Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by OTC Pain Medicines Revenue
3.4 Global OTC Pain Medicines Market Concentration Ratio
3.4.1 Global OTC Pain Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Pain Medicines Revenue in 2024
3.5 Global Key Players of OTC Pain Medicines Head office and Area Served
3.6 Global Key Players of OTC Pain Medicines, Product and Application
3.7 Global Key Players of OTC Pain Medicines, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Pain Medicines Breakdown Data by Type
4.1 Global OTC Pain Medicines Historic Market Size by Type (2020-2025)
4.2 Global OTC Pain Medicines Forecasted Market Size by Type (2026-2031)
5 OTC Pain Medicines Breakdown Data by Application
5.1 Global OTC Pain Medicines Historic Market Size by Application (2020-2025)
5.2 Global OTC Pain Medicines Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America OTC Pain Medicines Market Size (2020-2031)
6.2 North America OTC Pain Medicines Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America OTC Pain Medicines Market Size by Country (2020-2025)
6.4 North America OTC Pain Medicines Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC Pain Medicines Market Size (2020-2031)
7.2 Europe OTC Pain Medicines Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe OTC Pain Medicines Market Size by Country (2020-2025)
7.4 Europe OTC Pain Medicines Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Pain Medicines Market Size (2020-2031)
8.2 Asia-Pacific OTC Pain Medicines Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific OTC Pain Medicines Market Size by Region (2020-2025)
8.4 Asia-Pacific OTC Pain Medicines Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC Pain Medicines Market Size (2020-2031)
9.2 Latin America OTC Pain Medicines Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America OTC Pain Medicines Market Size by Country (2020-2025)
9.4 Latin America OTC Pain Medicines Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Pain Medicines Market Size (2020-2031)
10.2 Middle East & Africa OTC Pain Medicines Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa OTC Pain Medicines Market Size by Country (2020-2025)
10.4 Middle East & Africa OTC Pain Medicines Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline OTC Pain Medicines Introduction
11.1.4 GlaxoSmithKline Revenue in OTC Pain Medicines Business (2020-2025)
11.1.5 GlaxoSmithKline Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer OTC Pain Medicines Introduction
11.2.4 Pfizer Revenue in OTC Pain Medicines Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis OTC Pain Medicines Introduction
11.3.4 Novartis Revenue in OTC Pain Medicines Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi OTC Pain Medicines Introduction
11.4.4 Sanofi Revenue in OTC Pain Medicines Business (2020-2025)
11.4.5 Sanofi Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer OTC Pain Medicines Introduction
11.5.4 Bayer Revenue in OTC Pain Medicines Business (2020-2025)
11.5.5 Bayer Recent Development
11.6 Mallinckrodt
11.6.1 Mallinckrodt Company Details
11.6.2 Mallinckrodt Business Overview
11.6.3 Mallinckrodt OTC Pain Medicines Introduction
11.6.4 Mallinckrodt Revenue in OTC Pain Medicines Business (2020-2025)
11.6.5 Mallinckrodt Recent Development
11.7 Anqiu Lu'an
11.7.1 Anqiu Lu'an Company Details
11.7.2 Anqiu Lu'an Business Overview
11.7.3 Anqiu Lu'an OTC Pain Medicines Introduction
11.7.4 Anqiu Lu'an Revenue in OTC Pain Medicines Business (2020-2025)
11.7.5 Anqiu Lu'an Recent Development
11.8 Granules India
11.8.1 Granules India Company Details
11.8.2 Granules India Business Overview
11.8.3 Granules India OTC Pain Medicines Introduction
11.8.4 Granules India Revenue in OTC Pain Medicines Business (2020-2025)
11.8.5 Granules India Recent Development
11.9 Farmson
11.9.1 Farmson Company Details
11.9.2 Farmson Business Overview
11.9.3 Farmson OTC Pain Medicines Introduction
11.9.4 Farmson Revenue in OTC Pain Medicines Business (2020-2025)
11.9.5 Farmson Recent Development
11.10 Hebei Jiheng
11.10.1 Hebei Jiheng Company Details
11.10.2 Hebei Jiheng Business Overview
11.10.3 Hebei Jiheng OTC Pain Medicines Introduction
11.10.4 Hebei Jiheng Revenue in OTC Pain Medicines Business (2020-2025)
11.10.5 Hebei Jiheng Recent Development
11.11 Zhejiang Kangle
11.11.1 Zhejiang Kangle Company Details
11.11.2 Zhejiang Kangle Business Overview
11.11.3 Zhejiang Kangle OTC Pain Medicines Introduction
11.11.4 Zhejiang Kangle Revenue in OTC Pain Medicines Business (2020-2025)
11.11.5 Zhejiang Kangle Recent Development
11.12 Sri Krishna Pharma
11.12.1 Sri Krishna Pharma Company Details
11.12.2 Sri Krishna Pharma Business Overview
11.12.3 Sri Krishna Pharma OTC Pain Medicines Introduction
11.12.4 Sri Krishna Pharma Revenue in OTC Pain Medicines Business (2020-2025)
11.12.5 Sri Krishna Pharma Recent Development
11.13 Anhui BBCA Likang
11.13.1 Anhui BBCA Likang Company Details
11.13.2 Anhui BBCA Likang Business Overview
11.13.3 Anhui BBCA Likang OTC Pain Medicines Introduction
11.13.4 Anhui BBCA Likang Revenue in OTC Pain Medicines Business (2020-2025)
11.13.5 Anhui BBCA Likang Recent Development
11.14 Seqens
11.14.1 Seqens Company Details
11.14.2 Seqens Business Overview
11.14.3 Seqens OTC Pain Medicines Introduction
11.14.4 Seqens Revenue in OTC Pain Medicines Business (2020-2025)
11.14.5 Seqens Recent Development
11.15 Xinhua Pharmaceutical
11.15.1 Xinhua Pharmaceutical Company Details
11.15.2 Xinhua Pharmaceutical Business Overview
11.15.3 Xinhua Pharmaceutical OTC Pain Medicines Introduction
11.15.4 Xinhua Pharmaceutical Revenue in OTC Pain Medicines Business (2020-2025)
11.15.5 Xinhua Pharmaceutical Recent Development
11.16 IOLCP
11.16.1 IOLCP Company Details
11.16.2 IOLCP Business Overview
11.16.3 IOLCP OTC Pain Medicines Introduction
11.16.4 IOLCP Revenue in OTC Pain Medicines Business (2020-2025)
11.16.5 IOLCP Recent Development
11.17 Granules Biocause
11.17.1 Granules Biocause Company Details
11.17.2 Granules Biocause Business Overview
11.17.3 Granules Biocause OTC Pain Medicines Introduction
11.17.4 Granules Biocause Revenue in OTC Pain Medicines Business (2020-2025)
11.17.5 Granules Biocause Recent Development
11.18 Strides Shasun
11.18.1 Strides Shasun Company Details
11.18.2 Strides Shasun Business Overview
11.18.3 Strides Shasun OTC Pain Medicines Introduction
11.18.4 Strides Shasun Revenue in OTC Pain Medicines Business (2020-2025)
11.18.5 Strides Shasun Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Pain Medicines Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Acetaminophen
1.2.3 Ibuprofen
1.2.4 Aspirin
1.2.5 Naproxen
1.2.6 Others
1.3 Market by Application
1.3.1 Global OTC Pain Medicines Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 E-Commerce
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Pain Medicines Market Perspective (2020-2031)
2.2 Global OTC Pain Medicines Growth Trends by Region
2.2.1 Global OTC Pain Medicines Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 OTC Pain Medicines Historic Market Size by Region (2020-2025)
2.2.3 OTC Pain Medicines Forecasted Market Size by Region (2026-2031)
2.3 OTC Pain Medicines Market Dynamics
2.3.1 OTC Pain Medicines Industry Trends
2.3.2 OTC Pain Medicines Market Drivers
2.3.3 OTC Pain Medicines Market Challenges
2.3.4 OTC Pain Medicines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Pain Medicines Players by Revenue
3.1.1 Global Top OTC Pain Medicines Players by Revenue (2020-2025)
3.1.2 Global OTC Pain Medicines Revenue Market Share by Players (2020-2025)
3.2 Global OTC Pain Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by OTC Pain Medicines Revenue
3.4 Global OTC Pain Medicines Market Concentration Ratio
3.4.1 Global OTC Pain Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Pain Medicines Revenue in 2024
3.5 Global Key Players of OTC Pain Medicines Head office and Area Served
3.6 Global Key Players of OTC Pain Medicines, Product and Application
3.7 Global Key Players of OTC Pain Medicines, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Pain Medicines Breakdown Data by Type
4.1 Global OTC Pain Medicines Historic Market Size by Type (2020-2025)
4.2 Global OTC Pain Medicines Forecasted Market Size by Type (2026-2031)
5 OTC Pain Medicines Breakdown Data by Application
5.1 Global OTC Pain Medicines Historic Market Size by Application (2020-2025)
5.2 Global OTC Pain Medicines Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America OTC Pain Medicines Market Size (2020-2031)
6.2 North America OTC Pain Medicines Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America OTC Pain Medicines Market Size by Country (2020-2025)
6.4 North America OTC Pain Medicines Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC Pain Medicines Market Size (2020-2031)
7.2 Europe OTC Pain Medicines Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe OTC Pain Medicines Market Size by Country (2020-2025)
7.4 Europe OTC Pain Medicines Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Pain Medicines Market Size (2020-2031)
8.2 Asia-Pacific OTC Pain Medicines Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific OTC Pain Medicines Market Size by Region (2020-2025)
8.4 Asia-Pacific OTC Pain Medicines Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC Pain Medicines Market Size (2020-2031)
9.2 Latin America OTC Pain Medicines Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America OTC Pain Medicines Market Size by Country (2020-2025)
9.4 Latin America OTC Pain Medicines Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Pain Medicines Market Size (2020-2031)
10.2 Middle East & Africa OTC Pain Medicines Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa OTC Pain Medicines Market Size by Country (2020-2025)
10.4 Middle East & Africa OTC Pain Medicines Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline OTC Pain Medicines Introduction
11.1.4 GlaxoSmithKline Revenue in OTC Pain Medicines Business (2020-2025)
11.1.5 GlaxoSmithKline Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer OTC Pain Medicines Introduction
11.2.4 Pfizer Revenue in OTC Pain Medicines Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis OTC Pain Medicines Introduction
11.3.4 Novartis Revenue in OTC Pain Medicines Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi OTC Pain Medicines Introduction
11.4.4 Sanofi Revenue in OTC Pain Medicines Business (2020-2025)
11.4.5 Sanofi Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer OTC Pain Medicines Introduction
11.5.4 Bayer Revenue in OTC Pain Medicines Business (2020-2025)
11.5.5 Bayer Recent Development
11.6 Mallinckrodt
11.6.1 Mallinckrodt Company Details
11.6.2 Mallinckrodt Business Overview
11.6.3 Mallinckrodt OTC Pain Medicines Introduction
11.6.4 Mallinckrodt Revenue in OTC Pain Medicines Business (2020-2025)
11.6.5 Mallinckrodt Recent Development
11.7 Anqiu Lu'an
11.7.1 Anqiu Lu'an Company Details
11.7.2 Anqiu Lu'an Business Overview
11.7.3 Anqiu Lu'an OTC Pain Medicines Introduction
11.7.4 Anqiu Lu'an Revenue in OTC Pain Medicines Business (2020-2025)
11.7.5 Anqiu Lu'an Recent Development
11.8 Granules India
11.8.1 Granules India Company Details
11.8.2 Granules India Business Overview
11.8.3 Granules India OTC Pain Medicines Introduction
11.8.4 Granules India Revenue in OTC Pain Medicines Business (2020-2025)
11.8.5 Granules India Recent Development
11.9 Farmson
11.9.1 Farmson Company Details
11.9.2 Farmson Business Overview
11.9.3 Farmson OTC Pain Medicines Introduction
11.9.4 Farmson Revenue in OTC Pain Medicines Business (2020-2025)
11.9.5 Farmson Recent Development
11.10 Hebei Jiheng
11.10.1 Hebei Jiheng Company Details
11.10.2 Hebei Jiheng Business Overview
11.10.3 Hebei Jiheng OTC Pain Medicines Introduction
11.10.4 Hebei Jiheng Revenue in OTC Pain Medicines Business (2020-2025)
11.10.5 Hebei Jiheng Recent Development
11.11 Zhejiang Kangle
11.11.1 Zhejiang Kangle Company Details
11.11.2 Zhejiang Kangle Business Overview
11.11.3 Zhejiang Kangle OTC Pain Medicines Introduction
11.11.4 Zhejiang Kangle Revenue in OTC Pain Medicines Business (2020-2025)
11.11.5 Zhejiang Kangle Recent Development
11.12 Sri Krishna Pharma
11.12.1 Sri Krishna Pharma Company Details
11.12.2 Sri Krishna Pharma Business Overview
11.12.3 Sri Krishna Pharma OTC Pain Medicines Introduction
11.12.4 Sri Krishna Pharma Revenue in OTC Pain Medicines Business (2020-2025)
11.12.5 Sri Krishna Pharma Recent Development
11.13 Anhui BBCA Likang
11.13.1 Anhui BBCA Likang Company Details
11.13.2 Anhui BBCA Likang Business Overview
11.13.3 Anhui BBCA Likang OTC Pain Medicines Introduction
11.13.4 Anhui BBCA Likang Revenue in OTC Pain Medicines Business (2020-2025)
11.13.5 Anhui BBCA Likang Recent Development
11.14 Seqens
11.14.1 Seqens Company Details
11.14.2 Seqens Business Overview
11.14.3 Seqens OTC Pain Medicines Introduction
11.14.4 Seqens Revenue in OTC Pain Medicines Business (2020-2025)
11.14.5 Seqens Recent Development
11.15 Xinhua Pharmaceutical
11.15.1 Xinhua Pharmaceutical Company Details
11.15.2 Xinhua Pharmaceutical Business Overview
11.15.3 Xinhua Pharmaceutical OTC Pain Medicines Introduction
11.15.4 Xinhua Pharmaceutical Revenue in OTC Pain Medicines Business (2020-2025)
11.15.5 Xinhua Pharmaceutical Recent Development
11.16 IOLCP
11.16.1 IOLCP Company Details
11.16.2 IOLCP Business Overview
11.16.3 IOLCP OTC Pain Medicines Introduction
11.16.4 IOLCP Revenue in OTC Pain Medicines Business (2020-2025)
11.16.5 IOLCP Recent Development
11.17 Granules Biocause
11.17.1 Granules Biocause Company Details
11.17.2 Granules Biocause Business Overview
11.17.3 Granules Biocause OTC Pain Medicines Introduction
11.17.4 Granules Biocause Revenue in OTC Pain Medicines Business (2020-2025)
11.17.5 Granules Biocause Recent Development
11.18 Strides Shasun
11.18.1 Strides Shasun Company Details
11.18.2 Strides Shasun Business Overview
11.18.3 Strides Shasun OTC Pain Medicines Introduction
11.18.4 Strides Shasun Revenue in OTC Pain Medicines Business (2020-2025)
11.18.5 Strides Shasun Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global OTC Pain Medicines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Acetaminophen
Table 3. Key Players of Ibuprofen
Table 4. Key Players of Aspirin
Table 5. Key Players of Naproxen
Table 6. Key Players of Others
Table 7. Global OTC Pain Medicines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global OTC Pain Medicines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global OTC Pain Medicines Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global OTC Pain Medicines Market Share by Region (2020-2025)
Table 11. Global OTC Pain Medicines Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global OTC Pain Medicines Market Share by Region (2026-2031)
Table 13. OTC Pain Medicines Market Trends
Table 14. OTC Pain Medicines Market Drivers
Table 15. OTC Pain Medicines Market Challenges
Table 16. OTC Pain Medicines Market Restraints
Table 17. Global OTC Pain Medicines Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global OTC Pain Medicines Market Share by Players (2020-2025)
Table 19. Global Top OTC Pain Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Pain Medicines as of 2024)
Table 20. Ranking of Global Top OTC Pain Medicines Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by OTC Pain Medicines Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of OTC Pain Medicines, Headquarters and Area Served
Table 23. Global Key Players of OTC Pain Medicines, Product and Application
Table 24. Global Key Players of OTC Pain Medicines, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global OTC Pain Medicines Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global OTC Pain Medicines Revenue Market Share by Type (2020-2025)
Table 28. Global OTC Pain Medicines Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global OTC Pain Medicines Revenue Market Share by Type (2026-2031)
Table 30. Global OTC Pain Medicines Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global OTC Pain Medicines Revenue Market Share by Application (2020-2025)
Table 32. Global OTC Pain Medicines Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global OTC Pain Medicines Revenue Market Share by Application (2026-2031)
Table 34. North America OTC Pain Medicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America OTC Pain Medicines Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America OTC Pain Medicines Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe OTC Pain Medicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe OTC Pain Medicines Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe OTC Pain Medicines Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific OTC Pain Medicines Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific OTC Pain Medicines Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific OTC Pain Medicines Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America OTC Pain Medicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America OTC Pain Medicines Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America OTC Pain Medicines Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa OTC Pain Medicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa OTC Pain Medicines Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa OTC Pain Medicines Market Size by Country (2026-2031) & (US$ Million)
Table 49. GlaxoSmithKline Company Details
Table 50. GlaxoSmithKline Business Overview
Table 51. GlaxoSmithKline OTC Pain Medicines Product
Table 52. GlaxoSmithKline Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 53. GlaxoSmithKline Recent Development
Table 54. Pfizer Company Details
Table 55. Pfizer Business Overview
Table 56. Pfizer OTC Pain Medicines Product
Table 57. Pfizer Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. Novartis Company Details
Table 60. Novartis Business Overview
Table 61. Novartis OTC Pain Medicines Product
Table 62. Novartis Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Sanofi Company Details
Table 65. Sanofi Business Overview
Table 66. Sanofi OTC Pain Medicines Product
Table 67. Sanofi Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 68. Sanofi Recent Development
Table 69. Bayer Company Details
Table 70. Bayer Business Overview
Table 71. Bayer OTC Pain Medicines Product
Table 72. Bayer Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 73. Bayer Recent Development
Table 74. Mallinckrodt Company Details
Table 75. Mallinckrodt Business Overview
Table 76. Mallinckrodt OTC Pain Medicines Product
Table 77. Mallinckrodt Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 78. Mallinckrodt Recent Development
Table 79. Anqiu Lu'an Company Details
Table 80. Anqiu Lu'an Business Overview
Table 81. Anqiu Lu'an OTC Pain Medicines Product
Table 82. Anqiu Lu'an Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 83. Anqiu Lu'an Recent Development
Table 84. Granules India Company Details
Table 85. Granules India Business Overview
Table 86. Granules India OTC Pain Medicines Product
Table 87. Granules India Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 88. Granules India Recent Development
Table 89. Farmson Company Details
Table 90. Farmson Business Overview
Table 91. Farmson OTC Pain Medicines Product
Table 92. Farmson Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 93. Farmson Recent Development
Table 94. Hebei Jiheng Company Details
Table 95. Hebei Jiheng Business Overview
Table 96. Hebei Jiheng OTC Pain Medicines Product
Table 97. Hebei Jiheng Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 98. Hebei Jiheng Recent Development
Table 99. Zhejiang Kangle Company Details
Table 100. Zhejiang Kangle Business Overview
Table 101. Zhejiang Kangle OTC Pain Medicines Product
Table 102. Zhejiang Kangle Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 103. Zhejiang Kangle Recent Development
Table 104. Sri Krishna Pharma Company Details
Table 105. Sri Krishna Pharma Business Overview
Table 106. Sri Krishna Pharma OTC Pain Medicines Product
Table 107. Sri Krishna Pharma Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 108. Sri Krishna Pharma Recent Development
Table 109. Anhui BBCA Likang Company Details
Table 110. Anhui BBCA Likang Business Overview
Table 111. Anhui BBCA Likang OTC Pain Medicines Product
Table 112. Anhui BBCA Likang Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 113. Anhui BBCA Likang Recent Development
Table 114. Seqens Company Details
Table 115. Seqens Business Overview
Table 116. Seqens OTC Pain Medicines Product
Table 117. Seqens Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 118. Seqens Recent Development
Table 119. Xinhua Pharmaceutical Company Details
Table 120. Xinhua Pharmaceutical Business Overview
Table 121. Xinhua Pharmaceutical OTC Pain Medicines Product
Table 122. Xinhua Pharmaceutical Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 123. Xinhua Pharmaceutical Recent Development
Table 124. IOLCP Company Details
Table 125. IOLCP Business Overview
Table 126. IOLCP OTC Pain Medicines Product
Table 127. IOLCP Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 128. IOLCP Recent Development
Table 129. Granules Biocause Company Details
Table 130. Granules Biocause Business Overview
Table 131. Granules Biocause OTC Pain Medicines Product
Table 132. Granules Biocause Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 133. Granules Biocause Recent Development
Table 134. Strides Shasun Company Details
Table 135. Strides Shasun Business Overview
Table 136. Strides Shasun OTC Pain Medicines Product
Table 137. Strides Shasun Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 138. Strides Shasun Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 142. Authors List of This Report
List of Figures
Figure 1. OTC Pain Medicines Picture
Figure 2. Global OTC Pain Medicines Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global OTC Pain Medicines Market Share by Type: 2024 VS 2031
Figure 4. Acetaminophen Features
Figure 5. Ibuprofen Features
Figure 6. Aspirin Features
Figure 7. Naproxen Features
Figure 8. Others Features
Figure 9. Global OTC Pain Medicines Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global OTC Pain Medicines Market Share by Application: 2024 VS 2031
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Drug Stores Case Studies
Figure 13. E-Commerce Case Studies
Figure 14. OTC Pain Medicines Report Years Considered
Figure 15. Global OTC Pain Medicines Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global OTC Pain Medicines Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global OTC Pain Medicines Market Share by Region: 2024 VS 2031
Figure 18. Global OTC Pain Medicines Market Share by Players in 2024
Figure 19. Global Top OTC Pain Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Pain Medicines as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by OTC Pain Medicines Revenue in 2024
Figure 21. North America OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America OTC Pain Medicines Market Share by Country (2020-2031)
Figure 23. United States OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe OTC Pain Medicines Market Share by Country (2020-2031)
Figure 27. Germany OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific OTC Pain Medicines Market Share by Region (2020-2031)
Figure 35. China OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America OTC Pain Medicines Market Share by Country (2020-2031)
Figure 43. Mexico OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa OTC Pain Medicines Market Share by Country (2020-2031)
Figure 47. Turkey OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. GlaxoSmithKline Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 52. Novartis Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 53. Sanofi Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 54. Bayer Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 55. Mallinckrodt Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 56. Anqiu Lu'an Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 57. Granules India Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 58. Farmson Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 59. Hebei Jiheng Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 60. Zhejiang Kangle Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 61. Sri Krishna Pharma Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 62. Anhui BBCA Likang Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 63. Seqens Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 64. Xinhua Pharmaceutical Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 65. IOLCP Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 66. Granules Biocause Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 67. Strides Shasun Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global OTC Pain Medicines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Acetaminophen
Table 3. Key Players of Ibuprofen
Table 4. Key Players of Aspirin
Table 5. Key Players of Naproxen
Table 6. Key Players of Others
Table 7. Global OTC Pain Medicines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global OTC Pain Medicines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global OTC Pain Medicines Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global OTC Pain Medicines Market Share by Region (2020-2025)
Table 11. Global OTC Pain Medicines Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global OTC Pain Medicines Market Share by Region (2026-2031)
Table 13. OTC Pain Medicines Market Trends
Table 14. OTC Pain Medicines Market Drivers
Table 15. OTC Pain Medicines Market Challenges
Table 16. OTC Pain Medicines Market Restraints
Table 17. Global OTC Pain Medicines Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global OTC Pain Medicines Market Share by Players (2020-2025)
Table 19. Global Top OTC Pain Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Pain Medicines as of 2024)
Table 20. Ranking of Global Top OTC Pain Medicines Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by OTC Pain Medicines Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of OTC Pain Medicines, Headquarters and Area Served
Table 23. Global Key Players of OTC Pain Medicines, Product and Application
Table 24. Global Key Players of OTC Pain Medicines, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global OTC Pain Medicines Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global OTC Pain Medicines Revenue Market Share by Type (2020-2025)
Table 28. Global OTC Pain Medicines Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global OTC Pain Medicines Revenue Market Share by Type (2026-2031)
Table 30. Global OTC Pain Medicines Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global OTC Pain Medicines Revenue Market Share by Application (2020-2025)
Table 32. Global OTC Pain Medicines Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global OTC Pain Medicines Revenue Market Share by Application (2026-2031)
Table 34. North America OTC Pain Medicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America OTC Pain Medicines Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America OTC Pain Medicines Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe OTC Pain Medicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe OTC Pain Medicines Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe OTC Pain Medicines Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific OTC Pain Medicines Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific OTC Pain Medicines Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific OTC Pain Medicines Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America OTC Pain Medicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America OTC Pain Medicines Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America OTC Pain Medicines Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa OTC Pain Medicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa OTC Pain Medicines Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa OTC Pain Medicines Market Size by Country (2026-2031) & (US$ Million)
Table 49. GlaxoSmithKline Company Details
Table 50. GlaxoSmithKline Business Overview
Table 51. GlaxoSmithKline OTC Pain Medicines Product
Table 52. GlaxoSmithKline Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 53. GlaxoSmithKline Recent Development
Table 54. Pfizer Company Details
Table 55. Pfizer Business Overview
Table 56. Pfizer OTC Pain Medicines Product
Table 57. Pfizer Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. Novartis Company Details
Table 60. Novartis Business Overview
Table 61. Novartis OTC Pain Medicines Product
Table 62. Novartis Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Sanofi Company Details
Table 65. Sanofi Business Overview
Table 66. Sanofi OTC Pain Medicines Product
Table 67. Sanofi Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 68. Sanofi Recent Development
Table 69. Bayer Company Details
Table 70. Bayer Business Overview
Table 71. Bayer OTC Pain Medicines Product
Table 72. Bayer Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 73. Bayer Recent Development
Table 74. Mallinckrodt Company Details
Table 75. Mallinckrodt Business Overview
Table 76. Mallinckrodt OTC Pain Medicines Product
Table 77. Mallinckrodt Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 78. Mallinckrodt Recent Development
Table 79. Anqiu Lu'an Company Details
Table 80. Anqiu Lu'an Business Overview
Table 81. Anqiu Lu'an OTC Pain Medicines Product
Table 82. Anqiu Lu'an Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 83. Anqiu Lu'an Recent Development
Table 84. Granules India Company Details
Table 85. Granules India Business Overview
Table 86. Granules India OTC Pain Medicines Product
Table 87. Granules India Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 88. Granules India Recent Development
Table 89. Farmson Company Details
Table 90. Farmson Business Overview
Table 91. Farmson OTC Pain Medicines Product
Table 92. Farmson Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 93. Farmson Recent Development
Table 94. Hebei Jiheng Company Details
Table 95. Hebei Jiheng Business Overview
Table 96. Hebei Jiheng OTC Pain Medicines Product
Table 97. Hebei Jiheng Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 98. Hebei Jiheng Recent Development
Table 99. Zhejiang Kangle Company Details
Table 100. Zhejiang Kangle Business Overview
Table 101. Zhejiang Kangle OTC Pain Medicines Product
Table 102. Zhejiang Kangle Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 103. Zhejiang Kangle Recent Development
Table 104. Sri Krishna Pharma Company Details
Table 105. Sri Krishna Pharma Business Overview
Table 106. Sri Krishna Pharma OTC Pain Medicines Product
Table 107. Sri Krishna Pharma Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 108. Sri Krishna Pharma Recent Development
Table 109. Anhui BBCA Likang Company Details
Table 110. Anhui BBCA Likang Business Overview
Table 111. Anhui BBCA Likang OTC Pain Medicines Product
Table 112. Anhui BBCA Likang Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 113. Anhui BBCA Likang Recent Development
Table 114. Seqens Company Details
Table 115. Seqens Business Overview
Table 116. Seqens OTC Pain Medicines Product
Table 117. Seqens Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 118. Seqens Recent Development
Table 119. Xinhua Pharmaceutical Company Details
Table 120. Xinhua Pharmaceutical Business Overview
Table 121. Xinhua Pharmaceutical OTC Pain Medicines Product
Table 122. Xinhua Pharmaceutical Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 123. Xinhua Pharmaceutical Recent Development
Table 124. IOLCP Company Details
Table 125. IOLCP Business Overview
Table 126. IOLCP OTC Pain Medicines Product
Table 127. IOLCP Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 128. IOLCP Recent Development
Table 129. Granules Biocause Company Details
Table 130. Granules Biocause Business Overview
Table 131. Granules Biocause OTC Pain Medicines Product
Table 132. Granules Biocause Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 133. Granules Biocause Recent Development
Table 134. Strides Shasun Company Details
Table 135. Strides Shasun Business Overview
Table 136. Strides Shasun OTC Pain Medicines Product
Table 137. Strides Shasun Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 138. Strides Shasun Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 142. Authors List of This Report
List of Figures
Figure 1. OTC Pain Medicines Picture
Figure 2. Global OTC Pain Medicines Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global OTC Pain Medicines Market Share by Type: 2024 VS 2031
Figure 4. Acetaminophen Features
Figure 5. Ibuprofen Features
Figure 6. Aspirin Features
Figure 7. Naproxen Features
Figure 8. Others Features
Figure 9. Global OTC Pain Medicines Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global OTC Pain Medicines Market Share by Application: 2024 VS 2031
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Drug Stores Case Studies
Figure 13. E-Commerce Case Studies
Figure 14. OTC Pain Medicines Report Years Considered
Figure 15. Global OTC Pain Medicines Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global OTC Pain Medicines Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global OTC Pain Medicines Market Share by Region: 2024 VS 2031
Figure 18. Global OTC Pain Medicines Market Share by Players in 2024
Figure 19. Global Top OTC Pain Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Pain Medicines as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by OTC Pain Medicines Revenue in 2024
Figure 21. North America OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America OTC Pain Medicines Market Share by Country (2020-2031)
Figure 23. United States OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe OTC Pain Medicines Market Share by Country (2020-2031)
Figure 27. Germany OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific OTC Pain Medicines Market Share by Region (2020-2031)
Figure 35. China OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America OTC Pain Medicines Market Share by Country (2020-2031)
Figure 43. Mexico OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa OTC Pain Medicines Market Share by Country (2020-2031)
Figure 47. Turkey OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. GlaxoSmithKline Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 52. Novartis Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 53. Sanofi Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 54. Bayer Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 55. Mallinckrodt Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 56. Anqiu Lu'an Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 57. Granules India Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 58. Farmson Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 59. Hebei Jiheng Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 60. Zhejiang Kangle Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 61. Sri Krishna Pharma Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 62. Anhui BBCA Likang Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 63. Seqens Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 64. Xinhua Pharmaceutical Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 65. IOLCP Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 66. Granules Biocause Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 67. Strides Shasun Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Fatigue Analysis Engineering Services Market Research Report 2025
Jul 29, 25
Global Blast Impact Analysis Engineering Services Market Research Report 2025
Jul 29, 25
Global On-Line Analytical Processing (OLAP) Business Intelligence Consulting Services Market Research Report 2025
Jul 29, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232